Similar articles

• PET and SPECT in brain tumors and epilepsy.

  Horky LL, Treves ST. Horky LL, et al. Neurosurg Clin N Am. 2011 Apr;22(2):169-84, viii. doi: 10.1016/j.nec.2010.12.003. Neurosurg Clin N Am. 2011. PMID: 21435569 Review.
• Neuroprotection and imaging studies in Parkinson's disease.

  Pavese N, Kiferle L, Piccini P. Pavese N, et al. Parkinsonism Relat Disord. 2009 Dec;15 Suppl 4:S33-7. doi: 10.1016/S1353-8020(09)70832-6. Parkinsonism Relat Disord. 2009. PMID: 20123554 Review.
• Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging.

  Silverman DH. Silverman DH. J Nucl Med. 2004 Apr;45(4):594-607. J Nucl Med. 2004. PMID: 15073255 Review.
• Imagerie cérébrale dans les syndromes parkinsoniens.

  Prange S, Hermier M, Danaila T, Laurencin C, Thobois S. Prange S, et al. Presse Med. 2017 Mar;46(2 Pt 1):202-209. doi: 10.1016/j.lpm.2016.09.025. Epub 2016 Dec 28. Presse Med. 2017. PMID: 28040345 French.
• 99mTc-Tetrofosmin SPECT for the detection of glioma recurrence.

  Alexiou GA, Tsiouris S, Kyritsis AP, Polyzoidis KS, Fotopoulos AD. Alexiou GA, et al. Eur J Nucl Med Mol Imaging. 2008 Aug;35(8):1571-2. doi: 10.1007/s00259-008-0824-z. Epub 2008 May 20. Eur J Nucl Med Mol Imaging. 2008. PMID: 18491087 No abstract available.